微生物学。结核病——一个新靶点，一种新药。 - Suppr

Suppr

超能文献

Microbiology. TB--a new target, a new drug.

作者信息

Cole Stewart T, Alzari Pedro M

机构信息

Génétique Moléculaire Bactérienne and Biochimie Structurale Units, Institut Pasteur, Paris 75724 Cedex 15, France.

出版信息

Science. 2005 Jan 14;307(5707):214-5. doi: 10.1126/science.1108379.

DOI:10.1126/science.1108379

PMID:15653490

Abstract

摘要

相似文献

Microbiology. TB--a new target, a new drug.

Science. 2005 Jan 14;307(5707):214-5. doi: 10.1126/science.1108379.

Shortening the treatment of tuberculosis.

Nat Biotechnol. 2005 Feb;23(2):187-8. doi: 10.1038/nbt0205-187.

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Science. 2005 Jan 14;307(5707):223-7. doi: 10.1126/science.1106753. Epub 2004 Dec 9.

Medicine. New TB drug promises shorter, simpler treatment.

Science. 2004 Dec 10;306(5703):1872. doi: 10.1126/science.306.5703.1872.

Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.

Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.

Bioorg Med Chem. 2015 Feb 15;23(4):742-52. doi: 10.1016/j.bmc.2014.12.060. Epub 2015 Jan 2.

Infectious disease. Approval of novel TB drug celebrated--with restraint.

Science. 2013 Jan 11;339(6116):130. doi: 10.1126/science.339.6116.130.

Toward a new therapy for tuberculosis.

N Engl J Med. 2005 Mar 3;352(9):933-4. doi: 10.1056/NEJMcibr044438.

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.

Science. 2015 Jun 5;348(6239):1106-12. doi: 10.1126/science.aaa4690.

Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.

Pharmacotherapy. 2014 Nov;34(11):1187-97. doi: 10.1002/phar.1482. Epub 2014 Sep 9.

引用本文的文献

Analyzing the Effect of Resveratrol on Pharmacokinetics of Antituberculosis Drug Bedaquiline in Rats by a Novel UPLC-MS/MS Approach.

ACS Omega. 2024 Nov 25;9(49):48650-48656. doi: 10.1021/acsomega.4c07752. eCollection 2024 Dec 10.

Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future.

Curr Top Med Chem. 2024;24(21):1829-1855. doi: 10.2174/0115680266286294240610102911.

Design of peptides interfering with iron-dependent regulator (IdeR) and evaluation of growth inhibition.

Iran J Basic Med Sci. 2017 Jun;20(6):722-728. doi: 10.22038/IJBMS.2017.8859.

A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase.

Curr Med Chem. 2017 Nov 20;24(35):3894-3906. doi: 10.2174/0929867324666170823125330.

ATP synthase: the right size base model for nanomotors in nanomedicine.

ScientificWorldJournal. 2014 Jan 29;2014:567398. doi: 10.1155/2014/567398. eCollection 2014.

Bedaquiline metabolism: enzymes and novel metabolites.

Drug Metab Dispos. 2014 May;42(5):863-6. doi: 10.1124/dmd.113.056119. Epub 2014 Feb 10.

Improved synthesis of capuramycin and its analogues.

Chemistry. 2013 Oct 4;19(41):13847-58. doi: 10.1002/chem.201302389. Epub 2013 Sep 6.

ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Curr Med Chem. 2013;20(15):1956-73. doi: 10.2174/0929867311320150003.

Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Br J Pharmacol. 2012 Aug;166(8):2331-47. doi: 10.1111/j.1476-5381.2012.01958.x.

Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.

J Med Chem. 2012 Apr 26;55(8):3739-55. doi: 10.1021/jm201608g. Epub 2012 Apr 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Microbiology. TB--a new target, a new drug.

Science. 2005 Jan 14;307(5707):214-5. doi: 10.1126/science.1108379.

Shortening the treatment of tuberculosis.

Nat Biotechnol. 2005 Feb;23(2):187-8. doi: 10.1038/nbt0205-187.

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Science. 2005 Jan 14;307(5707):223-7. doi: 10.1126/science.1106753. Epub 2004 Dec 9.

Medicine. New TB drug promises shorter, simpler treatment.

Science. 2004 Dec 10;306(5703):1872. doi: 10.1126/science.306.5703.1872.

Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.

Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.

Bioorg Med Chem. 2015 Feb 15;23(4):742-52. doi: 10.1016/j.bmc.2014.12.060. Epub 2015 Jan 2.

Infectious disease. Approval of novel TB drug celebrated--with restraint.

Science. 2013 Jan 11;339(6116):130. doi: 10.1126/science.339.6116.130.

Toward a new therapy for tuberculosis.

N Engl J Med. 2005 Mar 3;352(9):933-4. doi: 10.1056/NEJMcibr044438.

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.

Science. 2015 Jun 5;348(6239):1106-12. doi: 10.1126/science.aaa4690.

Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.

Pharmacotherapy. 2014 Nov;34(11):1187-97. doi: 10.1002/phar.1482. Epub 2014 Sep 9.

引用本文的文献

Analyzing the Effect of Resveratrol on Pharmacokinetics of Antituberculosis Drug Bedaquiline in Rats by a Novel UPLC-MS/MS Approach.

ACS Omega. 2024 Nov 25;9(49):48650-48656. doi: 10.1021/acsomega.4c07752. eCollection 2024 Dec 10.

Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future.

Curr Top Med Chem. 2024;24(21):1829-1855. doi: 10.2174/0115680266286294240610102911.

Design of peptides interfering with iron-dependent regulator (IdeR) and evaluation of growth inhibition.

Iran J Basic Med Sci. 2017 Jun;20(6):722-728. doi: 10.22038/IJBMS.2017.8859.

A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase.

Curr Med Chem. 2017 Nov 20;24(35):3894-3906. doi: 10.2174/0929867324666170823125330.

ATP synthase: the right size base model for nanomotors in nanomedicine.

ScientificWorldJournal. 2014 Jan 29;2014:567398. doi: 10.1155/2014/567398. eCollection 2014.

Bedaquiline metabolism: enzymes and novel metabolites.

Drug Metab Dispos. 2014 May;42(5):863-6. doi: 10.1124/dmd.113.056119. Epub 2014 Feb 10.

Improved synthesis of capuramycin and its analogues.

Chemistry. 2013 Oct 4;19(41):13847-58. doi: 10.1002/chem.201302389. Epub 2013 Sep 6.

ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Curr Med Chem. 2013;20(15):1956-73. doi: 10.2174/0929867311320150003.

Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Br J Pharmacol. 2012 Aug;166(8):2331-47. doi: 10.1111/j.1476-5381.2012.01958.x.

Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.

J Med Chem. 2012 Apr 26;55(8):3739-55. doi: 10.1021/jm201608g. Epub 2012 Apr 6.